ResMed Inc. (0KW4.L)
USD 233.41
(-3.67%)
USD 233.41
(-3.67%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 6.87 Billion USD | 1.79% |
| 2023 | 6.75 Billion USD | 32.49% |
| 2022 | 5.09 Billion USD | 7.78% |
| 2021 | 4.72 Billion USD | 3.07% |
| 2020 | 4.58 Billion USD | 11.68% |
| 2019 | 4.1 Billion USD | 34.07% |
| 2018 | 3.06 Billion USD | -11.66% |
| 2017 | 3.46 Billion USD | 6.43% |
| 2016 | 3.25 Billion USD | 49.2% |
| 2015 | 2.18 Billion USD | -7.48% |
| 2014 | 2.36 Billion USD | 6.8% |
| 2013 | 2.21 Billion USD | 3.41% |
| 2012 | 2.13 Billion USD | 3.33% |
| 2011 | 2.06 Billion USD | 27.21% |
| 2010 | 1.62 Billion USD | 7.85% |
| 2009 | 1.5 Billion USD | 7.25% |
| 2008 | 1.4 Billion USD | 12.3% |
| 2007 | 1.25 Billion USD | 24.31% |
| 2006 | 1 Billion USD | 30.11% |
| 2005 | 774.14 Million USD | 42.26% |
| 2004 | 544.15 Million USD | 18.4% |
| 2003 | 459.59 Million USD | 22.17% |
| 2002 | 376.19 Million USD | 30.58% |
| 2001 | 288.09 Million USD | 149.23% |
| 2000 | 115.59 Million USD | 28.58% |
| 1999 | 89.9 Million USD | 39.16% |
| 1998 | 64.6 Million USD | 17.67% |
| 1997 | 54.9 Million USD | 17.06% |
| 1996 | 46.9 Million USD | 32.86% |
| 1995 | 35.3 Million USD | 267.71% |
| 1994 | 9.6 Million USD | 84.62% |
| 1993 | 5.2 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 FY | 6.87 Billion USD | 1.79% |
| 2024 Q1 | 6.74 Billion USD | -0.16% |
| 2024 Q2 | 6.9 Billion USD | 2.44% |
| 2024 Q4 | 6.87 Billion USD | 0.85% |
| 2024 Q3 | 6.81 Billion USD | -1.31% |
| 2023 Q3 | 6.71 Billion USD | 0.57% |
| 2023 FY | 6.75 Billion USD | 32.49% |
| 2023 Q1 | 5.17 Billion USD | 1.6% |
| 2023 Q2 | 6.67 Billion USD | 28.94% |
| 2023 Q4 | 6.75 Billion USD | 0.56% |
| 2022 Q3 | 4.9 Billion USD | 3.6% |
| 2022 Q1 | 4.72 Billion USD | 0.02% |
| 2022 Q2 | 4.73 Billion USD | 0.12% |
| 2022 FY | 5.09 Billion USD | 7.78% |
| 2022 Q4 | 5.09 Billion USD | 3.89% |
| 2021 Q1 | 4.62 Billion USD | 0.73% |
| 2021 FY | 4.72 Billion USD | 3.07% |
| 2021 Q2 | 4.57 Billion USD | -1.04% |
| 2021 Q3 | 4.58 Billion USD | 0.28% |
| 2021 Q4 | 4.72 Billion USD | 3.11% |
| 2020 FY | 4.58 Billion USD | 11.68% |
| 2020 Q2 | 4.35 Billion USD | 4.8% |
| 2020 Q3 | 4.51 Billion USD | 3.6% |
| 2020 Q4 | 4.58 Billion USD | 1.7% |
| 2020 Q1 | 4.15 Billion USD | 1.14% |
| 2019 Q1 | 3.06 Billion USD | 0.12% |
| 2019 Q3 | 4.09 Billion USD | 6.18% |
| 2019 Q2 | 3.85 Billion USD | 25.83% |
| 2019 Q4 | 4.1 Billion USD | 0.22% |
| 2019 FY | 4.1 Billion USD | 34.07% |
| 2018 Q1 | 3.48 Billion USD | 0.61% |
| 2018 Q4 | 3.06 Billion USD | -13.31% |
| 2018 Q3 | 3.53 Billion USD | -0.84% |
| 2018 FY | 3.06 Billion USD | -11.66% |
| 2018 Q2 | 3.56 Billion USD | 2.13% |
| 2017 Q2 | 3.32 Billion USD | 0.01% |
| 2017 Q1 | 3.32 Billion USD | 1.94% |
| 2017 Q4 | 3.46 Billion USD | 1.34% |
| 2017 FY | 3.46 Billion USD | 6.43% |
| 2017 Q3 | 3.42 Billion USD | 3.01% |
| 2016 Q4 | 3.25 Billion USD | 33.31% |
| 2016 FY | 3.25 Billion USD | 49.2% |
| 2016 Q2 | 2.23 Billion USD | -0.69% |
| 2016 Q1 | 2.25 Billion USD | 3.22% |
| 2016 Q3 | 2.44 Billion USD | 9.18% |
| 2015 Q1 | 2.3 Billion USD | -2.18% |
| 2015 FY | 2.18 Billion USD | -7.48% |
| 2015 Q2 | 2.32 Billion USD | 0.74% |
| 2015 Q3 | 2.27 Billion USD | -2.09% |
| 2015 Q4 | 2.18 Billion USD | -4.12% |
| 2014 FY | 2.36 Billion USD | 6.8% |
| 2014 Q1 | 2.33 Billion USD | 5.61% |
| 2014 Q3 | 2.36 Billion USD | 0.81% |
| 2014 Q4 | 2.36 Billion USD | -0.15% |
| 2014 Q2 | 2.34 Billion USD | 0.47% |
| 2013 Q2 | 2.33 Billion USD | 3.82% |
| 2013 Q1 | 2.24 Billion USD | 5.0% |
| 2013 Q4 | 2.21 Billion USD | -6.92% |
| 2013 FY | 2.21 Billion USD | 3.41% |
| 2013 Q3 | 2.37 Billion USD | 1.91% |
| 2012 Q3 | 2.12 Billion USD | 4.28% |
| 2012 Q4 | 2.13 Billion USD | 0.42% |
| 2012 Q2 | 2.04 Billion USD | 5.49% |
| 2012 FY | 2.13 Billion USD | 3.33% |
| 2012 Q1 | 1.93 Billion USD | -6.46% |
| 2011 FY | 2.06 Billion USD | 27.21% |
| 2011 Q2 | 1.88 Billion USD | 5.13% |
| 2011 Q3 | 1.96 Billion USD | 4.14% |
| 2011 Q4 | 2.06 Billion USD | 5.44% |
| 2011 Q1 | 1.79 Billion USD | 10.2% |
| 2010 FY | 1.62 Billion USD | 7.85% |
| 2010 Q2 | 1.62 Billion USD | 0.07% |
| 2010 Q1 | 1.62 Billion USD | 7.44% |
| 2010 Q3 | 1.71 Billion USD | 5.69% |
| 2010 Q4 | 1.62 Billion USD | -5.08% |
| 2009 Q4 | 1.5 Billion USD | 13.75% |
| 2009 FY | 1.5 Billion USD | 7.25% |
| 2009 Q3 | 1.32 Billion USD | 1.42% |
| 2009 Q2 | 1.3 Billion USD | 1.12% |
| 2009 Q1 | 1.29 Billion USD | -8.06% |
| 2008 Q4 | 1.4 Billion USD | 2.94% |
| 2008 Q2 | 1.31 Billion USD | 2.45% |
| 2008 Q1 | 1.28 Billion USD | 2.86% |
| 2008 FY | 1.4 Billion USD | 12.3% |
| 2008 Q3 | 1.36 Billion USD | 3.52% |
| 2007 Q4 | 1.25 Billion USD | 5.05% |
| 2007 FY | 1.25 Billion USD | 24.31% |
| 2007 Q3 | 1.19 Billion USD | 5.25% |
| 2007 Q2 | 1.13 Billion USD | 9.83% |
| 2007 Q1 | 1.03 Billion USD | 2.36% |
| 2006 Q2 | 860.04 Million USD | 5.33% |
| 2006 Q3 | 899.12 Million USD | 4.54% |
| 2006 Q4 | 1 Billion USD | 12.02% |
| 2006 FY | 1 Billion USD | 30.11% |
| 2006 Q1 | 816.49 Million USD | 5.47% |
| 2005 Q4 | 774.14 Million USD | 14.81% |
| 2005 Q3 | 674.3 Million USD | 7.98% |
| 2005 Q2 | 624.49 Million USD | 10.51% |
| 2005 Q1 | 565.1 Million USD | 3.85% |
| 2005 FY | 774.14 Million USD | 42.26% |
| 2004 FY | 544.15 Million USD | 18.4% |
| 2004 Q4 | 544.15 Million USD | 0.5% |
| 2004 Q3 | 541.44 Million USD | 6.9% |
| 2004 Q2 | 506.47 Million USD | 4.08% |
| 2004 Q1 | 486.63 Million USD | 5.88% |
| 2003 Q3 | 420.26 Million USD | 8.56% |
| 2003 FY | 459.59 Million USD | 22.17% |
| 2003 Q2 | 387.13 Million USD | 2.79% |
| 2003 Q1 | 376.61 Million USD | 0.11% |
| 2003 Q4 | 459.59 Million USD | 9.36% |
| 2002 Q2 | 351.42 Million USD | 2.92% |
| 2002 Q3 | 341.14 Million USD | -2.93% |
| 2002 Q4 | 376.19 Million USD | 10.27% |
| 2002 FY | 376.19 Million USD | 30.58% |
| 2002 Q1 | 341.47 Million USD | 18.53% |
| 2001 Q2 | 140.24 Million USD | 10.36% |
| 2001 Q1 | 127.08 Million USD | 9.94% |
| 2001 FY | 288.09 Million USD | 149.23% |
| 2001 Q4 | 288.09 Million USD | 43.36% |
| 2001 Q3 | 200.96 Million USD | 43.29% |
| 2000 Q2 | 103.8 Million USD | 7.23% |
| 2000 FY | 115.59 Million USD | 28.58% |
| 2000 Q1 | 96.8 Million USD | 7.68% |
| 2000 Q4 | 115.59 Million USD | 3.95% |
| 2000 Q3 | 111.2 Million USD | 7.13% |
| 1999 Q3 | 83 Million USD | 9.93% |
| 1999 FY | 89.9 Million USD | 39.16% |
| 1999 Q1 | 67.3 Million USD | 4.18% |
| 1999 Q2 | 75.5 Million USD | 12.18% |
| 1999 Q4 | 89.9 Million USD | 8.31% |
| 1998 Q4 | 64.6 Million USD | 9.86% |
| 1998 FY | 64.6 Million USD | 17.67% |
| 1998 Q2 | 57 Million USD | 1.06% |
| 1998 Q3 | 58.8 Million USD | 3.16% |
| 1998 Q1 | 56.4 Million USD | 2.73% |
| 1997 Q3 | 53.6 Million USD | 2.49% |
| 1997 FY | 54.9 Million USD | 17.06% |
| 1997 Q1 | 50.2 Million USD | 7.04% |
| 1997 Q2 | 52.3 Million USD | 4.18% |
| 1997 Q4 | 54.9 Million USD | 2.43% |
| 1996 FY | 46.9 Million USD | 32.86% |
| 1996 Q3 | 44.3 Million USD | 0.0% |
| 1996 Q4 | 46.9 Million USD | 5.87% |
| 1995 FY | 35.3 Million USD | 267.71% |
| 1995 Q4 | 35.3 Million USD | 0.0% |
| 1994 FY | 9.6 Million USD | 84.62% |
| 1994 Q4 | 9.6 Million USD | 0.0% |
| 1993 Q4 | 5.2 Million USD | 0.0% |
| 1993 FY | 5.2 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Phreesia, Inc. | 371.08 Million USD | -1751.973% |
| Accuray Incorporated | 468.62 Million USD | -1366.496% |
| Align Technology, Inc. | 6.08 Billion USD | -12.961% |
| Elevance Health Inc. | 108.92 Billion USD | 93.691% |
| AxoGen, Inc. | 196.82 Million USD | -3391.591% |
| Boston Scientific Corporation | 35.13 Billion USD | 80.441% |
| CVS Health Corporation | 249.72 Billion USD | 97.248% |
| Cardinal Health, Inc. | 45.12 Billion USD | 84.769% |
| Centene Corporation | 84.64 Billion USD | 91.881% |
| DaVita Inc. | 17.61 Billion USD | 60.995% |
| HCA Healthcare, Inc. | 56.21 Billion USD | 87.774% |
| Hologic, Inc. | 9.15 Billion USD | 24.941% |
| Humana Inc. | 47.06 Billion USD | 85.398% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | -110.814% |
| Laboratory Corporation of America Holdings | 16.72 Billion USD | 58.91% |
| Masimo Corporation | 3.04 Billion USD | -125.954% |
| McKesson Corporation | 67.44 Billion USD | 89.81% |
| Patterson Companies, Inc. | 2.96 Billion USD | -131.467% |
| Quest Diagnostics Incorporated | 14.02 Billion USD | 50.988% |
| Henry Schein, Inc. | 10.57 Billion USD | 35.001% |
| Teladoc Health, Inc. | 4.39 Billion USD | -56.462% |
| Universal Health Services, Inc. | 14.35 Billion USD | 52.132% |
| Veeva Systems Inc. | 5.91 Billion USD | -16.266% |
| Baxter International Inc. | 28.27 Billion USD | 75.695% |
| Becton, Dickinson and Company | 52.78 Billion USD | 86.979% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | 55.494% |
| Danaher Corporation | 84.48 Billion USD | 91.866% |
| Stryker Corporation | 39.91 Billion USD | 82.781% |
| Medtronic plc | 89.98 Billion USD | 92.362% |